Organon Pharma Indonesia Tbk. vs Tira Austenite Tbk — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Tira Austenite Tbk trades at Rp408 (market cap 238.73B, 802.2K 24h volume). The key difference: Tira Austenite Tbk is far larger — about 2.3× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| SCPI | TIRA | |
|---|---|---|
Market Cap | 104.4B | 238.73B |
Volume | — | 802.2K |
Lot | — | 8.02K |
Turnover | — | 314.71M |
Average Price | — | 392.31 |
Value | — | 314.71M |
Indicative Equilibrium Price | — | 408 |
Indicative Equilibrium Volume | — | 63 |
Trailing returns across standard periods
Latest headlines on both assets
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →PT. Tira Austenite is a manufacturer and distributor of industrial products and specialized in steel and welding machines and rods produced by ASSAB/UDDEHOLM and MESSER LINCOLN GmbH. The company has 13 branches throughout Indonesia.
Read more on TIRA →